Skip to content
Review

Subcutaneous Administration of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) for Pain Management: A Systematic Review and Meta-Analysis.

Sep 2026 · Journal of Pain & Palliative Care Pharmacotherapy · pp. 1-10 · 0 citations · 28 references
Medicine

TL;DR

Subcutaneous diclofenac and ketorolac may reduce short-term acute pain compared with placebo, however, the evidence is limited and safety remains uncertain.

Abstract

This review aimed to evaluate the efficacy and safety of subcutaneous nonsteroidal anti-inflammatory drugs (NSAIDs). We searched CENTRAL, MEDLINE, Embase, trial registries, and Google Scholar until December 19, 2024. Eligible studies were randomized controlled trials (RCTs) in adults comparing subcutaneous NSAIDs with other routes of administration, placebo, no treatment, or other drugs. The primary outcome was pain intensity; secondary outcomes were rescue medication use and adverse events. We assessed risk of bias using the Risk of Bias 2 tool. Random-effects meta-analyses used standardized mean differences (SMDs) for pain intensity and odds ratios for rescue medication use. Adverse events were summarized narratively. Four RCTs (n = 825) were included: three placebo-controlled trials and one route-comparison trial, all evaluating short-term treatment for acute pain with subcutaneous diclofenac or ketorolac. In the meta-analysis of three placebo-controlled trials (n = 500), subcutaneous NSAIDs reduced pain (SMD = 0.72; 95% CI, 0.22 to 1.21; I2 = 82.8%) and rescue medication use. Adverse-event data were limited and inconsistent, with one trial reporting higher event rates with subcutaneous NSAIDs than placebo and another reporting comparable rates. The route-comparison trial showed comparable efficacy and safety between subcutaneous and intramuscular diclofenac. In conclusion, subcutaneous diclofenac and ketorolac may reduce short-term acute pain compared with placebo. However, the evidence is limited and safety remains uncertain. Further route-comparison studies are needed.

View source

Similar papers

Review Open access Sep 2026

Safety Profile of the Non-steroidal Anti-inflammatory Drug Celecoxib in the Short-Term Management of Acute Non-cancer Pain: A Systematic Review with Meta-analysis of Randomised Controlled Trials

Celecoxib appears to be safe for acute non-cancer pain when compared to placebo, NSAIDS, and opioids, and had a lower risk compared to opioids for gastrointestinal adverse events in general, nausea and vomiting, as well as a lower risk for nausea adverse events when compared to placebo and nsNSAIDS.

Carlos I. Mesa-Castrillon, Ye Tian, J. Hughes et al. · 0 citations
Review Open access Oct 2026

Efficacy of systemic enzyme therapy as an anti-inflammatory agent when used as monotherapy or in combination with NSAIDs: A systematic review.

Systemic enzyme therapy (SET) has emerged as a potential anti-inflammatory intervention, either as monotherapy or in combination with non-steroidal anti-inflammatory drugs (NSAIDs). Despite its increasing clinical application, the comparative efficacy of SET in various inflammatory conditions remains insufficiently exp...

G. Shivakumar, N. Abdul, Mahesh Shenoy et al. · 0 citations
Review Open access Jan 2026

Clinical Effects of Photobiomodulation, Corticosteroids, and Nonsteroidal Anti‐Inflammatory Drugs Following Third Molar Surgery: A Systematic Review of Randomized Clinical Trials

The three approaches may improve different postoperative outcomes, but the available evidence does not support a definitive hierarchy among them.

Erick Andres Alpaca Zevallos, Luciano Leocádio Teixeira Nogueira, Anderson Jara Ferreira et al. · 0 citations
Review Sep 2026

Efficacy and Safety of Cannabinoid-Based Interventions for Low Back Pain and Migraine: A Systematic Review of Randomized Controlled Trials.

INTRODUCTION Low back pain, migraine, and other headache disorders are major contributors to disability, and interest in cannabinoid-based interventions has increased despite uncertainty regarding their indication-specific therapeutic value. This systematic review evaluated the efficacy and safety of isolated cannabino...

Claudete da Costa-Oliveira, Magnólia de Jesus Castro, Luiza Aparecida Luna Silvério et al. · 0 citations
Review Open access Sep 2026

Safety and Analgesic Outcomes of Nonsteroidal Anti-Inflammatory Drug-Containing Regimens After Transoral Robotic Surgery: A Systematic Review and Meta-Analysis.

NSAIDs improved analgesia and reduced opioid use after TORS without significantly increasing POH risk, supporting NSAID integration into postoperative protocols.

Rahul D. Patel, Connor J. Dorais, Tristen Hofmann et al. · 1 citation
Review Open access Sep 2026

The Efficacy of Different Treatment Options in Cutaneous Sarcoidosis: A Meta-analysis of RCTs

Pharmacological add-on therapies showed no significant efficacy beyond corticosteroids but may improve quality of life, and risk of bias ranged from moderate to high, with low statistical heterogeneity.

F. Thianich, Katharina M. Wörgötter, Linda Bruckner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.